Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors

NCT00084734 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: capecitabine
DRUG: cisplatin
DRUG: docetaxel

Sponsor

Roswell Park Cancer Institute